Epidemiology of hypopituitarism and pituitary tumors;Epidemiología del hipopituitarismo y los tumores hipofisarios

Medicina Clinica

Volumn 119, Issue 9, 2002, Pages 345-350

  Regal Vźquez, Milagros ^a   García Mayor, Ricardo V ^a  

^a HOSPITAL XERAL CÍES   (Spain)

Author keywords

Growth hormone deficiency; Hypopituitarism; Incidence; Pituitary tumors; Prevalence

Indexed keywords

AUTOPSY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS TUMOR; HYPOPITUITARISM; INCIDENCE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PUBLICATION; REVIEW; SYMPTOMATOLOGY; AGE; SEX DIFFERENCE;

AGE FACTORS; HUMANS; HYPOPITUITARISM; INCIDENCE; PITUITARY NEOPLASMS; PREVALENCE; SEX FACTORS;

EID: 0037152050     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)73410-6     Document Type: Review

References (85)

1. Vance M. Hypopituitarism. N Engl J Med 1994;330:1651-62.
2. Hill G, Forbes W, Kozak J. A simple method for estimating incidence from prevalence. Chronic Dis Can 1999;20:151-3.
3. Ahlbom A, Norell S. ¿Qué es la epidemiología? Fundamentos de epidemiología. Madrid: Siglo XXI, 1987; p. 1-4.
4. Webb S. Foreword. En: Webb S, editor. Pituitary tumours: Epidemiology, Pathogenesis and Management. Bristol: BioScientifica Ltd., 1998.
5. Lamberts S. Foreword. In: Lamberts S, editor. The diagnosis and treatment of pituitary insufficiency. Bristol: BioScientifica Ltd., 1997.
6. McGauley G. Quality of life. En: Johannsson G, Jorgensen J, Russel-Jones D, editors. Treatment of GH deficiency in adults. Oxford: OCC Ltd., 1998; p. 24-28.
7. Rosen T, Bengtsson B. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-8.
8. Bülow B, Hagmar L, Micoczy Z, Nordström C, Erfurth E. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997;46:75-81.
9. Bülow B, Hagmar L, Eskilsson J, Erfurth E. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocr Metab 2000;85:574-84.
10. Tomlinson J, Holden N, Hills R, Wheatley K, Clayton R, Bates A, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001;357:425-31.
11. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K. Increased fracture rate in adults with hypopituitarism and GH deficiency. Eur J Endocrinol 1997;137:240-5.
12. Carroll P, Christ E, Bengtsson B. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocr Metab 1998;83:382-95.
13. Gibney J, Wallace J, Spinks T, Schnorr L, Ranicar A, Cuneo R. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J Clin Endocr Metab 1999;84:2596-602.
14. Sanmartí A, Lucas A, Hawkins F, Webb S, Ulied A. Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socio-economic impact and health status. Eur J Endocrinol 1999;141:481-9.
15. Ehrnborg C, Roijen LH-V, Jonsson B, Rutten F, Bengtsson B, Rosen T. Cost of illness in adult patients with hypopituitarism. Pharmacoeconomics 2000;17:621-8.
16. Shalet S, Peacey S. Treatment strategies in the prevention of growth hormone deficiency. En: Lamberts S, editor. The diagnosis and treatment of pituitary insufficiency. Bristol: BioScientifica Ltd, 1997; p. 263-79.
17. Tugwell P, Bennett K, Sackett D, Haynes R. The measurement iterative loop: a framework for the critical appraisal of need, benefits and costs of health interventions. J Chron Dis 1985;38:339-51.
18. Ahlbom A, Norell S. Medidas de frecuencia de enfermedad. Fundamentos de epidemiología. Madrid: Siglo XXI, 1987; p. 5-17.
19. Bates A, Hoff WVt, Jones P, Clayton R. The effect of hypopituitarism on life expectancy. J Clin Endocr Metab 1996;81:1169-72.
20. Regal M, Páramo C, Sierra J, García-Mayor R. Prevalence and incidence of hypopituitarism in adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 2001;55:735-40.
21. Bates A, Hoff WVt, Jones J, Clayton R. An audit of outcome of treatment in acromegaly. Q J Med 1993;86:293-9.
22. Wellbourn R. Survival and causes of death after adrenalectomy for Cushing's disease. Surgery 1985;97:16-20.
23. Plotz C, Knowlton A, Ragan C. The natural history of Cushing's syndrome. Am J Med 1952; 13:597-613.
24. Etxabe J, Vázquez J. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 1994;40:479-84.
25. Parkin J. Incidence of growth hormone deficiency. Arch Dis Child 1974; 49:904-5.
26. Vimpani G, Vimpani A, Lidgard G, Cameron E, Farquhar J. Prevalence of severe growth hormone deficiency. BMJ 1977;2:427-30.
27. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994;125:29-35.
28. Nerup J. Addison's disease-a review of some clinical, pathological and immunological features. Dan Med Bull 1974;21:201.
29. Stuart-Mason A, Mead T, Lee J, Morris J. Epidemiological and clinical picture of Addison's disease. Lancet 1968;2:744.
30. Hanna C, Krainz P, Skeels M, Miyahira R, Sesser D, LaFranchi S. Detection of congenital hypopituitary hypothyraidism: ten-year experience in the Northwest Regional Screening Program. J Pediatr 1986;109:959-64.
31. Helfand M, Crapo L. Screening for thyroid disease. Ann Intern Med 1990;112:840-9.
32. Tunbridge W, Caldwell G. The epidemiology of thyroid diseases. En: Braverman L, Utiger R, editors. The thyroid: a fundamental and clinical text. Philadelphia: Lippincott, 1991; p. 578-87.
33. Utiger R. The thyroid: physiology, thyrotoxicosis, hypothyroidism, and the painful thyroid. En: Felig P, Baxter J, Frohman L, editors. Endocrinology and metabolism. New York: McGraw-Hill, 1995; p. 435-519.
34. Galofré J, García-Mayor R, Fluiters E, Fernández-Calvet L, Rego A, Páramo C, et al. Incidence of different forms of thyroid dysfunction and its degrees in an iodine sufficient area. Thyroidol Clin Exp 1994;6:49-54.
35. Fromantin M, Gineste J, Didier A. Les impuberismes et les hypogonadismes a l'incorporation. Probl Actuels Endocrinol Nutr 1972;16:179.
36. Rugarli E, Ballabio A. Kallmann syndrome. JAMA 1993;270:2713-6.
37. Marelli A, Cappellini A, Madini G, Bisceglie G, Boldori L. Vasopressin-sensitive diabetes insipidus. Case histories. Minerva Med 1992;83:207-11.
38. Wong M, Chin N, Lew T. Diabetes insipidus in neurosurgical patients. Ann Acad Med Singapore 1998;27:340-3.
39. Barret T, Bundey S, Macleod A. Neurodegeneration and diabetes; UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995;346:1458-63.
40. Clayton R. Symptoms, signs and long-term outcomes of adulthood acquired hypopituitarism. En: Lamberts S, editor. The diagnosis and treatment of pituitary insufficiency. Bristol: BioScientifica, 1997; p. 3-19.
41. Ambrosi B, Faglia G. Epidemiology of pituitary tumors. Excerpta Medica Int Congr Ser 1991;961:159-68.
42. Susman W. Pituitary adenoma. BMJ 1933;2:1215.
43. Costello R. Subclinical adenoma of the pituitary gland. Am J Pathol 1936;12:205.
44. Teramoto A, Hirakawa K, Sanno N. Incidental pituitary lesions in 1000 unselected autopsy specimens. Radiology 1994;193:161.
45. Muhr C, Bergstrom K, Grimelius L. A parallel study of the roentgen anatomy of the sella turcica and the histopathology of the pituitary gland in 205 autopsy specimens. Neuroradiology 1981;21:55.
46. Burrow G, Wortzman G, Rewcastle N. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304:156-8.
47. Molitch M, Russell E. The pituitary «incidentaloma». Ann Intern Med 1990;112:925-31.
48. Auer R, Alakija P, Sutherland G. Asymptomatic large pituitary adenomas discovered at autopsy. Surg Neurol 1996;46:28.
49. Melmed S, Braunstein G, Horvath E, Ezrin C, Kovacs K. Pathophysiology of acromegaly. Endocrinol Rev 1983;4:271-90.
50. Faglia G. Epidemiology and pathogenesis of pituitary adenomas. Acta Endocrinol 1993;129(Suppl);1-5.
51. Elster A. Modern imaging of the pituitary. Radiology 1993;187:1-14.
52. Molitch M. Pituitary incidentalomas. En: Young W, Klee G, editors. Diagnostic evaluation update. Endocrinol Metab Clin North Am. Vol. 26:4. Philadelphia: WB Saunders Company, 1997; p. 725-40.
53. Reincke M, Allolio B, Saeger W. The «incidentaloma» of the pituitary gland: is neurosurgery required? JAMA 1990;263:2772.
54. Donovan L, Corenblum B. The natural history of the pituitary incidentaloma. Arch Intern Med 1995;153:181.
55. Scheithauer B. Surgical pathology of the pituitary: the adenomas. Part I. Pathol Annu 1984;19:317-74.
56. Walker A, Robins M, Weinfeld F. Epidemiology of brain tumours: the national survey of intracranial neoplasms. Neurology 1985;35:219-26.
57. Kovacs K, Horvath E. Tumors of the pituirary gland. En: Harmanm W, editor. Atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology, 1986; p. 1.
58. Asa S. The pathology of pituitary tumors. En: Molitch M, editor. Advances in the management of pituitary tumors. Endocrinol Metab Clin North Am 1999;28:13-43.
59. Gold E. Epidemiology of pituitary adenomas. Epidemiol Rev 1981;3:163-83.
60. Heshmat M, Kovi J, Simpson C. Neoplasms of the central nervous system. Incidence and population selectivity in the Washington DC, Metropolitan Area. Cancer 1976;38:2135-42.
61. Schoenberg B, Christine B, Whisnant J. The descriptive epidemiology of primary intracranial neoplasms: the Connecticut experience. Am J Epidemiol 1976;104:499-510.
62. Leibowitz U, Yablonski M, Alter M. Tumors of the nervous system: incidence and population selectivity. J Chron Dis 1971;23:707-21.
63. Leibowitz U, Yablonski M, Alter M. Epidemiology of tumors of the nervous system in Israel. Isr J Med Sci 1971;7:1491-9.
64. Percy A, Elveback L, Okazaki H. Neoplasms of the central nervous system: elpidemiologic considerations. Neurology 1972;22:40-8.
65. Robinson N, Beral V, Ashley J. Incidence of pituitary adenoma in women. Lancet 1979;2:630.
66. Nilsson B, Gustavsson-Kadaka E, Bengtsson B-A, Jonsson B. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 2000;85:1420-5.
67. Annegers J, Coulam C, Abboud C. Pituitary adenoma in Olmsted County, Minnesota, 1935-1977. Mayo Clin Proc 1978;53:641-3.
68. Collins W. Adenomas of the pituitary gland -an epidemic? Surg Clin North Am 1980;60:1201-6.
69. Terada T, Kovacs K, Stefaneanu L. Incidence, pathology, and recurrence of pituitary adenomas: Study of 647 unselected surgical cases. Endocrinol Pathol 1995;6:301-10.
70. Mindermann T, Wilson C. Age-related and gender-related ocurrence of pituitary adenomas. Clin Endocrinol 1994;41:359-64.
71. Kovacs K, Ryan N, Horvath E. Pituitary adenomas in old age. J Gerontol 1980;35:16-22.
72. Melmed S. Pathogenesis of pituitary tumors. En: Molitch M, editor. Advances in the Management of Pituitary Tumors. Enclocrinol Metab Clin North Am 1999;28:1-12.
73. Kane L, Leinung M, Scheithauer B. Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab 1994;79:1135-40.
74. Mukai K, Seljeskog E, Dehner L. Pituitary adenomas in patients under 20 years old: a clinicopathological study of 12 cases. J Neuro-Oncol 1986;4:79-89.
75. Molitch M. Prolactinoma. En: Melmed S, editor. The pituitary. Cambridge, MA: Blackwell Science, 1995; p. 443-77.
76. Klibanski A, Zervas N. Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 1991;324:822-31.
77. Shimon I, Melmed S. Management of pituitary tumors. Ann Intern Med 1998;129:472-83.
78. Salvador J, Sopena M. Tumores hipofisarios no funcionantes. Endocrinología 1996;43:350-61.
79. Bengtsson B, Edén S, Ernest I, Odén A, Sjogren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988;223:327-35.
80. Alexander L, Appleton D, Hall R, Ross W, Wilkinson R. Epidemiology of acromegalia in the Newcastle region. Clin Endocrinol 1980;12:71-9.
81. Ritchie C, Atkinson A, Kennedy A, Lyons A, Gordon D, Fannin T, et al. Ascertainment and natural history of treated acromegaly in Northern Ireland. Ulster Med J 1990;59:55-62.
82. Etxabe J, Gaztambide S, Latorre P, Vázquez J. Acromegaly: an epidemiological study. J Endocrinol Invest 1993;16:181-7.
83. Beck-Peccoz P, Brucker-Davis F, Persani L. Thyrotropin-secreting pituitary tumors. Endocrinol Rev 1996;17:610-38.
84. Drange M, Fram N, Herman-Bonert V, Melmed S. Pituitary tumor registry: a novel clinical resource. J Clin Enclocrinol Metab 2000;85:168-74.
85. Albareda M. Registro Español de Acromegalia (REA): www.acromegalia.com. Endocrinología y Nutrición